271 related articles for article (PubMed ID: 29603431)
1. Durability of the hepatitis B vaccination in pediatric renal transplant recipients.
Miller-Handley H; Paulsen G; Hooper DK; Lake M; Lazear D; Danziger-Isakov L
Clin Transplant; 2018 May; 32(5):e13247. PubMed ID: 29603431
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
[TBL] [Abstract][Full Text] [Related]
3. Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients.
Querido S; Weigert A; Adragão T; Rodrigues L; Jorge C; Bruges M; Machado D
Transpl Infect Dis; 2019 Feb; 21(1):e13009. PubMed ID: 30295412
[TBL] [Abstract][Full Text] [Related]
4. Factors Affecting the Development of an Antibody Response to Hepatitis B Immunization in Children With Intestinal Failure: Before and After Small Bowel Transplantation (With and Without Liver Graft).
Craggs HM; Jackson P; Gupte G; Hartley J; Abdel-Hady M; Morton R; Beath S; Hogg L
JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):1030-1036. PubMed ID: 26962060
[TBL] [Abstract][Full Text] [Related]
5. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
[TBL] [Abstract][Full Text] [Related]
7. Utilizing increased risk for disease transmission (IRD) kidneys for pediatric renal transplant recipients.
Hwang CS; Gattineni J; MacConmara M
Pediatr Nephrol; 2019 Oct; 34(10):1743-1751. PubMed ID: 31243535
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
Takahata M; Hashino S; Onozawa M; Shigematsu A; Sugita J; Fujimoto K; Endo T; Kondo T; Tanaka J; Imamura M; Teshima T
Transpl Infect Dis; 2014 Oct; 16(5):797-801. PubMed ID: 25154638
[TBL] [Abstract][Full Text] [Related]
9. Assessing vaccine-induced immunity against pneumococcus, hepatitis A and B over a 9-year follow-up in pediatric liver transplant recipients: A nationwide retrospective study.
Gold T; Gualtieri R; Posfay-Barbe K; Wildhaber BE; McLin V; Blanchard-Rohner G
Am J Transplant; 2024 Jun; 24(6):1070-1079. PubMed ID: 38103788
[TBL] [Abstract][Full Text] [Related]
10. Impact of body mass index on immunogenicity of hepatitis B vaccine in bariatric surgery candidates: A retrospective study.
Kabir A; Lotfi S; Farsi F; Pazouki A
Diabetes Metab Syndr; 2021; 15(5):102254. PubMed ID: 34450550
[TBL] [Abstract][Full Text] [Related]
11. Successful active immunization using a hepatitis B virus vaccination protocol for a recipient with hepatitis B core antibody-positive liver graft.
Ohno Y; Mita A; Ikegami T; Masuda Y; Urata K; Nakazawa Y; Kobayashi A; Miyagawa S
Transplant Proc; 2014 Apr; 46(3):721-5. PubMed ID: 24767333
[TBL] [Abstract][Full Text] [Related]
12. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of hepatitis B-antibody loss and a case report of
Sintusek P; Posuwan N; Wanawongsawad P; Jitraruch S; Poovorawan Y; Chongsrisawat V
World J Gastroenterol; 2018 Feb; 24(6):752-762. PubMed ID: 29456414
[TBL] [Abstract][Full Text] [Related]
14. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
[TBL] [Abstract][Full Text] [Related]
15. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer.
Kaloyannidis P; Batsis I; Yannaki E; Adamidou D; Bartzoudis D; Papathanasiou M; Mallouri D; Sakellari I; Fassas A; Anagnostopoulos A
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1049-56. PubMed ID: 17697967
[TBL] [Abstract][Full Text] [Related]
16. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
Lee S; Kim JM; Choi GS; Park JB; Kwon CH; Choe YH; Joh JW; Lee SK
Liver Transpl; 2016 Feb; 22(2):247-51. PubMed ID: 26600319
[TBL] [Abstract][Full Text] [Related]
17. Vaccine-induced protection against hepatitis B in pediatric solid organ transplant patients.
Ball M; Liverman R; Serluco A; Yildirim I
Pediatr Transplant; 2021 May; 25(3):e13920. PubMed ID: 33217081
[TBL] [Abstract][Full Text] [Related]
18. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
[TBL] [Abstract][Full Text] [Related]
19. A comparison of post-transplant renal function in pre-emptive and post-dialysis pediatric kidney transplant recipients.
Kim JK; Lorenzo AJ; Farhat WA; Chua ME; Ming JM; Dos Santos J; Koyle MA
Pediatr Transplant; 2019 May; 23(3):e13377. PubMed ID: 30735602
[TBL] [Abstract][Full Text] [Related]
20. Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation.
Lin CC; Yong CC; Chen CL
World J Gastroenterol; 2015 Oct; 21(39):11112-7. PubMed ID: 26494965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
